OMNIOME CLOSES $60 MILLION SERIES C FINANCING TO ADVANCE NOVEL GENOMIC SEQUENCING PLATFORM
January 9, 2020

Company Raises $145 Million in Eighteen Months to Complete Development and Early Commercialization of Breakthrough DNA Sequencing Platform

SAN DIEGO—January 9, 2020 – Omniome, Inc., developer of an innovative DNA sequencing platform capable of delivering unsurpassed sequencing accuracy, today announced it has raised an additional $60 million with the completion of its Series C financing. The funding round was led by Madrone Capital Partners. Current investors include ARCH Venture Partners, Decheng Capital, Domain Associates, Biomatics Capital Partners, Altitude Life Sciences Ventures, Nan Fung Life Sciences and others. The company, which raised $60 million in financing in mid-2018, will utilize the new $60 million equity financing in addition to previous debt financing in order to accelerate late-stage product development and launch planning. “Our product development efforts are advancing rapidly and shifting towards delivering our first beta prototype instruments”, said Dave Mullarkey, President and CEO at Omniome. “We welcome Madrone and appreciate ongoing support from our current investors in executing on our plans.” The company will deploy portions of the financing proceeds to expand the company’s capabilities by hiring new team members across multiple disciplines, particularly in manufacturing, engineering, development, customer support and commercial. The company will continue to optimize its proprietary technology while accelerating instrument development and delivery of commercially-impactful sequencing platforms. “Omniome has made incredible progress over the past couple years maturing from an early product concept company to a late stage product development company”, said Ken Song, M.D., Omniome’s Executive Chairman. “The goal and vision have always been to develop a disruptive sequencing technology taking into account accuracy, speed, throughput, and cost. The team’s success in advancing product development across these dimensions has attracted considerable interest from top tier investors.”

Copyright ? 2011 Decheng Capital LLC. All Rights Reserved.
浙江20选5预测推荐 mg电子的注单号在哪查 江西多乐彩前三走势图 澳客网北单比分直播网 比特币平台app正规吗 欢乐升级看不懂怎么玩 威尼斯真人游戏 ag视讯 二分彩大小单双必赢打法 双彩网吉林11选5 瑞典vs瑞士比分预测 个人如何理财投资公司 ag捕鱼王心得 福利彩票带坐标走势图带连线 ag视讯大厅 任选9场预测 山东老11选5遗漏